Secondary brain injury after aneurysmal subarachnoid haemorrhage: more than vasospasm
-
Published:2011-07
Issue:7
Volume:10
Page:593-595
-
ISSN:1474-4422
-
Container-title:The Lancet Neurology
-
language:en
-
Short-container-title:The Lancet Neurology
Author:
Rabinstein Alejandro A
Subject
Clinical Neurology
Reference11 articles.
1. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage;Rinkel;Lancet Neurol,2011
2. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution;Macdonald;Nat Clin Pract Neurol,2007
3. Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function;Vatter;J Neurosurg,2007
4. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study;Vajkoczy;J Neurosurg,2005
5. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial;Macdonald;Stroke,2008
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献